Comprehensive evaluation, diagnosis, staging and personalised treatment planning for oral cavity cancer, with treatment decisions based on the tumour's location, extent, pathology, lymph-node involvement, overall health and individual treatment goals.
Oral cancer refers to cancer arising in the tissues of the oral cavity. The oral cavity includes several different anatomical sites, and the location and extent of a tumour can influence both treatment and functional outcomes.
The oral cavity includes the front two-thirds of the tongue, gums, inner lining of the cheeks and lips, floor of the mouth, hard palate and retromolar trigone. Most cancers arising in these areas are squamous cell carcinomas, which develop from the thin, flat cells lining the oral cavity.
A persistent mouth ulcer, unusual patch, lump, unexplained bleeding, persistent pain or another change in the mouth does not necessarily mean cancer. However, persistent or unexplained oral changes should be assessed by an appropriate healthcare professional rather than being ignored or treated repeatedly without establishing the cause.
Oral cavity cancers can arise in different parts of the mouth. Identifying the exact site is important because the anatomy, surgical approach, reconstruction and treatment planning can vary.
Oral cavity cancer can develop in the front two-thirds of the tongue, also called the oral or anterior tongue.
Cancer may develop in the gingiva around the teeth and may sometimes involve underlying bone.
This is the inner lining of the cheeks and the inner surface of the lips.
The floor of the mouth is the area beneath the tongue and contains important muscles, glands and nearby structures.
The hard palate forms the bony front portion of the roof of the mouth.
This is the small area of tissue behind the last lower molar teeth and can be involved in oral cavity cancers.
The exact tumour type is established through pathological examination of tissue. Knowing the histology helps the oncology team understand the cancer and plan appropriate treatment.
Squamous cell carcinoma is the most common type of cancer arising in the oral cavity. It develops from squamous cells lining the mouth.
Less common tumours can also occur in oral tissues, including cancers arising from salivary gland or other specialised tissues. The diagnosis depends on biopsy and pathology.
Cancer cells can spread from the primary tumour to lymph nodes in the neck. Assessment of the neck is therefore an important part of staging and treatment planning for appropriate patients.
Cancer can sometimes return after treatment or spread beyond the original site. Treatment in these situations depends on the location of recurrence, previous treatment and whether disease is locally advanced or metastatic.
There is no single treatment plan that is appropriate for every oral cancer. The treatment approach is developed after evaluating the tumour and the person as a whole.
The exact part of the oral cavity involved can influence the surgical approach and the potential functional effects of treatment.
The size and depth of the tumour and involvement of nearby structures can affect treatment planning.
Whether cancer has spread to lymph nodes in the neck is an important consideration when determining stage and treatment.
Biopsy findings help establish the tumour type and other pathological characteristics relevant to treatment.
General health, nutrition, dental condition and other medical factors can influence treatment choices and recovery.
Speech, swallowing, chewing, appearance and quality of life are important considerations, particularly when surgery or reconstruction is required.
Oral cancer treatment may involve more than one specialist. Depending on the diagnosis and treatment plan, surgical, medical and radiation oncology expertise may be combined with dental, nutritional, speech and rehabilitation support.
Evaluates the primary tumour, surgical removal, neck lymph nodes and, when necessary, reconstruction and functional preservation.
Helps determine the role of systemic treatment, including chemotherapy, immunotherapy and other medicines when clinically appropriate.
Assesses whether radiation therapy may be appropriate before, after or instead of surgery in selected clinical situations.
An unexplained oral lesion does not necessarily mean cancer, but persistent changes deserve appropriate clinical evaluation. Bring previous dental, biopsy or imaging records when available.
Book an Oncology ConsultationOral cancer can cause changes in the mouth, tongue, gums or jaw. Some symptoms may also occur with infections, dental problems, injuries or other non-cancerous conditions. A persistent or unexplained change should be assessed rather than assumed to be cancer.
A sore or ulcer that does not heal, particularly when there is no obvious cause or it keeps returning in the same area, should be examined by a dentist or doctor.
A sore or ulcer on the lip, tongue, gums, cheek or another part of the mouth that does not heal normally.
A persistent white, red or mixed-colour patch on the gums, tongue or lining of the mouth should be evaluated.
An unexplained lump, thickening or area of swelling in the mouth, lip, cheek or gums may require further assessment.
Bleeding from an area of the mouth without an obvious dental or traumatic cause should be assessed if it persists.
Ongoing pain, tenderness, burning or unexplained numbness of the mouth or lip can have several causes and may need evaluation.
Difficulty moving the tongue normally or persistent changes affecting speech or oral function should not be ignored.
Persistent difficulty chewing or swallowing can have many causes but should be investigated when unexplained or progressive.
Unexplained loosening of teeth or dentures that suddenly stop fitting properly may warrant dental and medical assessment.
Persistent swelling of the jaw or difficulty opening the mouth normally should be assessed, especially when associated with another oral change.
A persistent throat discomfort may have many causes. If it occurs together with an oral lesion, swallowing difficulty or another unexplained symptom, medical evaluation is appropriate.
A persistent lump in the neck can have several causes, including enlarged lymph nodes, and should be evaluated if it does not resolve.
Unintentional weight loss is not specific to oral cancer but can occur with advanced disease or other medical conditions and warrants assessment when unexplained.
No. Many common conditions can cause changes inside the mouth. The appearance of a lesion alone cannot reliably determine whether it is cancerous.
Some oral cancers can initially resemble common mouth ulcers, patches or other oral problems. A healthcare professional may need to examine the lesion, assess the surrounding tissues and, when indicated, arrange further testing or biopsy.
A risk factor increases the likelihood of developing a disease, but having a risk factor does not mean that a person has cancer. Some people develop oral cancer without an obvious known risk factor.
Smoking and smokeless tobacco products are important risk factors for cancers of the oral cavity. This includes chewing tobacco and other forms of tobacco exposure.
Betel quid chewing, including products containing areca nut, is an important oral cancer risk factor in South Asia and other regions where these products are used.
Alcohol is an independent risk factor for cancers of the oral cavity and other head and neck sites. Risk increases with greater alcohol exposure.
Using tobacco and alcohol together is associated with a greater risk of head and neck cancers than using either exposure alone.
A previous head and neck cancer can increase the risk of developing another primary cancer in the head and neck region.
Certain HPV infections are associated with cancers of the head and neck. The strongest established association is with oropharyngeal cancer, while the role of HPV in oral cavity cancer is less clear.
HPV is an important cause of many oropharyngeal cancers, particularly cancers involving the tonsils and base of the tongue. This should not be confused with cancers arising in the front two-thirds of the tongue or other parts of the oral cavity.
Because the anatomical site matters, an oral cavity cancer should be diagnosed and characterised based on clinical examination, biopsy and appropriate investigations rather than assuming that HPV is the cause.
Consider arranging an evaluation when an oral or related symptom is persistent, unexplained, recurrent or progressively worsening.
Early evaluation can help establish whether a change is related to a dental condition, infection, inflammation or another cause, and whether further investigation is needed.
Book an Oncology ConsultationIf an oral lesion or other finding raises concern, the diagnostic process aims to establish whether cancer is present, identify the tumour type and determine how far it has extended. Diagnosis and staging are related but are not the same process.
The mouth, tongue, gums, cheeks, palate and floor of the mouth are examined. The neck is also assessed for enlarged or abnormal lymph nodes.
A sample of the suspicious tissue is obtained and examined by a pathologist to determine whether cancer is present.
CT, MRI and, when appropriate, PET-CT help evaluate the primary tumour, nearby structures, lymph nodes and possible distant spread.
Clinical, pathological and imaging findings are brought together to determine the extent of disease and guide treatment planning.
A detailed examination is an important first step when oral cancer is suspected. The doctor or dentist may examine the mouth directly and feel the tissues and neck to identify abnormalities.
The lips, inner cheeks, gums, tongue, floor of the mouth and roof of the mouth may be inspected and palpated.
The clinician may assess the size, location, surface, consistency and mobility of a suspicious lesion.
The lymph nodes of the neck are assessed because oral cavity cancers can spread to regional lymph nodes.
A neck lump does not automatically mean that cancer has spread. Further examination or imaging may be required to establish its cause.
A biopsy involves removing a sample of tissue from a suspicious area so that it can be examined under a microscope. A biopsy is the definitive diagnostic method for determining whether an oral cavity lesion is cancerous.
Once tissue has been obtained, the pathology report provides information that helps the oncology team understand the tumour and plan treatment.
The report identifies the type of cancer, with squamous cell carcinoma being the most common type in the oral cavity.
The pathology report may provide information about features such as differentiation and other microscopic characteristics relevant to clinical management.
If surgery is performed, the final specimen can provide additional information about tumour extent, margins, depth of invasion, lymphovascular or perineural involvement and lymph nodes.
Imaging is selected according to the suspected tumour site, clinical findings and stage. Different scans answer different clinical questions.
CT can provide detailed information about the tumour and is particularly useful for assessing involvement of structures such as the jawbone. Contrast-enhanced CT may also help assess the neck and other areas when indicated.
MRI provides detailed soft-tissue information and can help assess the extent of an oral cavity tumour and involvement of nearby soft tissues or nerves.
PET-CT may be considered in selected situations to evaluate lymph nodes or possible disease outside the primary site, particularly when more advanced disease is suspected.
Ultrasound can help evaluate lymph nodes in the neck and may be used to guide a needle biopsy of a suspicious node.
Dental assessment may be important before treatment, particularly when radiation therapy or surgery involving the oral cavity is being considered.
In selected patients, examination of adjacent upper aerodigestive structures may be recommended depending on the tumour location, symptoms and clinical findings.
The lymph nodes of the neck are an important part of oral cancer staging because cancer cells can travel from the primary tumour to regional lymph nodes.
The neck is examined for enlarged, firm or otherwise abnormal lymph nodes during the initial clinical assessment.
An abnormal-feeling lymph node does not by itself establish metastatic cancer and may require imaging or tissue sampling.
Ultrasound, CT or other imaging can help identify suspicious nodes. When appropriate, a fine-needle aspiration or other tissue sampling procedure may be used to evaluate a node.
Oral cavity cancer is commonly staged using the TNM system. Staging describes how extensive the cancer is and helps the oncology team plan treatment. The assessment considers the primary tumour, regional lymph nodes and distant spread.
Describes the size and local extent of the primary tumour. For oral cavity cancer, depth of invasion is also an important component of T classification.
Describes whether nearby lymph nodes contain cancer and, when involved, considers their number, size, location and other features.
Describes whether cancer has spread to distant parts of the body, such as the lungs or other organs.
Understanding these terms can make an oral cancer diagnosis less confusing.
Answers: “Is this cancer, and what type is it?”
Biopsy and pathology are central to establishing the diagnosis.
Answers: “How extensive is the cancer?”
Clinical examination, pathology, imaging and lymph-node assessment contribute to staging.
Understanding the pathology report and stage is an important first step before discussing surgery, radiation or systemic treatment. Bring your biopsy and imaging reports for a specialist review.
Book an Oncology ConsultationTreatment for oral cavity cancer is selected according to the tumour's location and extent, lymph-node status, pathology, overall health and treatment goals. Some patients require one treatment modality, while others benefit from a combination of surgery, radiation therapy and, in selected situations, systemic treatment.
Surgery may remove the primary tumour with an appropriate margin of surrounding tissue. Depending on the tumour and lymph-node risk, neck dissection and reconstruction may also be required.
Radiation may be used as the main local treatment in selected situations or after surgery when pathological or clinical features indicate an increased risk of recurrence.
Chemotherapy may be combined with radiation in selected locally advanced or unresectable head and neck cancers. The exact approach depends on the clinical situation.
Immunotherapy can be used for selected recurrent or metastatic oral cavity squamous cell carcinomas, depending on the disease setting and treatment eligibility.
Drug treatment may be considered when cancer is recurrent, unresectable or metastatic, or in selected combined-treatment strategies.
Nutrition, dental care, speech and swallowing support, rehabilitation and symptom management can be important parts of treatment and recovery.
When oral cavity cancer is limited to the primary site and can be adequately removed, surgery or radiation may be considered depending on the tumour's exact location and characteristics.
Wide local excision is commonly used to remove the tumour with an appropriate margin of surrounding tissue. The exact operation depends on the site, size and depth of the tumour.
Radiation therapy can be an alternative or part of treatment for selected oral cavity cancers. The suitability of radiation depends on the tumour site, size and clinical circumstances.
Even when the primary tumour appears localised, the risk of hidden lymph-node involvement may influence whether the neck requires treatment or close assessment.
Treatment planning considers preservation of speech, swallowing, chewing and appearance while maintaining appropriate cancer control.
Surgery is a common treatment for oral cavity cancer. The operation is tailored to the tumour's location and extent and may include treatment of the neck or reconstruction when necessary.
Removes the visible tumour together with an appropriate margin of surrounding tissue.
Selected tumours of the oral tongue may require partial removal of the tongue, with the extent determined by the tumour.
If cancer involves the mandible or maxilla, removal of the affected bone may be required as part of cancer surgery.
Lymph nodes and selected surrounding tissues may be removed when there is known or significant risk of regional spread.
Skin grafts, local or regional tissue, or free-flap reconstruction may be considered to restore structure and function after larger resections.
Dental care, speech and swallowing rehabilitation and nutritional support may be incorporated into recovery.
More extensive oral cavity cancers may require a combination of treatments. The exact sequence depends on whether the tumour is resectable, the extent of neck disease and the final pathological risk factors.
When surgery is appropriate, the primary tumour and relevant neck disease may be removed first.
After surgery, the pathology report is reviewed to determine whether postoperative radiation or combined postoperative treatment is indicated.
This approach is often described as adjuvant treatment.
Radiation may be used after surgery for selected patients at increased risk of local or regional recurrence.
In selected situations where surgery is not feasible or the disease cannot be safely removed, radiation-based treatment with systemic therapy may be considered.
External-beam radiation uses a machine to deliver carefully planned radiation to the tumour area and, when required, regional lymph-node areas.
Modern treatment planning aims to deliver the prescribed dose while limiting exposure to nearby normal tissues as much as possible.
Radiation may be recommended after surgery when pathological findings indicate a higher risk of recurrence.
The decision depends on the final pathology, margins, lymph nodes, tumour extent and other risk features.
Systemic treatment is not required for every person with oral cavity cancer. It becomes particularly relevant in selected locally advanced, recurrent or metastatic disease.
Chemotherapy may be combined with radiation in selected locally advanced disease or used as part of systemic treatment for recurrent or metastatic disease.
Drugs such as pembrolizumab or nivolumab may be used in appropriate recurrent or metastatic oral cavity squamous cell carcinoma. Biomarker testing may help inform treatment selection in relevant settings.
Depending on the disease setting, systemic treatment may be combined with other medicines or radiation. The choice depends on previous treatment, disease extent and overall health.
If oral cancer returns or spreads to distant parts of the body, the treatment plan is reassessed rather than automatically repeating the original treatment.
Surgery, radiation or a combination may be considered depending on the location of recurrence and treatments already received.
Recurrence involving lymph nodes or nearby tissues may require surgery, radiation, systemic treatment or a combination based on previous therapy and resectability.
When cancer has spread to distant organs, systemic treatment becomes an important part of management. Immunotherapy may be an option for appropriate patients.
Clinical trials may provide access to new treatments or new treatment combinations and can be considered when appropriate for the patient's clinical situation.
Two people with oral cancer may receive different treatment plans even when their diagnoses appear similar. Treatment decisions are based on the complete clinical picture.
Tongue, gum, cheek, floor of mouth, palate and other sites can require different surgical or radiation approaches.
Tumour size, depth of invasion and local extension influence treatment planning.
The presence and characteristics of lymph-node involvement can significantly affect treatment.
If surgery is performed, the final pathology helps determine whether the tumour has been adequately removed and whether additional treatment may be required.
Nutrition, dental health, other medical conditions and functional status can influence treatment and recovery.
Previous surgery, radiation or systemic treatment is especially important when planning treatment for recurrent disease.
Oral cancer treatment must balance cancer control with the functions and quality-of-life issues that matter to the patient.
A personalised treatment plan should take into account the tumour's location, pathology, stage, lymph-node findings, previous treatment and your functional goals.
Book an Oncology ConsultationOral cancer surgery is not one standard operation. The procedure is tailored to the anatomical site and extent of the tumour.
The tumour is removed together with a planned margin of surrounding tissue. The aim is to remove the visible tumour as well as microscopic disease that may extend beyond it.
Tumours involving the oral tongue may require removal of part of the tongue. The extent depends on the size, depth and location of the tumour.
Tumours of the floor of the mouth may require local excision and, when appropriate, removal of involved adjacent tissues.
Cancer of the inner cheek may be removed with surrounding tissue. Larger or deeper tumours may require more extensive resection and reconstruction.
If the tumour involves the mandible or maxilla, part of the affected bone may need to be removed as part of cancer surgery.
Tumours of the hard palate or upper or lower gums may require removal of involved oral tissues and, when necessary, underlying bone.
Some oral cavity tumours arise close to or extend into the jawbone. If the bone is involved, removing the affected portion may be necessary to achieve appropriate cancer clearance.
Tumours involving the lower gum, floor of mouth or nearby structures may extend towards the mandible.
Depending on the extent of involvement, surgery may range from a limited removal of part of the bone to a more extensive mandibular resection.
Cancers involving the upper gum or hard palate may extend into the maxilla.
The required operation depends on the location and extent of bone involvement and may be combined with reconstructive or prosthetic rehabilitation.
Oral cavity cancers can spread to lymph nodes in the neck. Depending on the tumour's risk of nodal involvement and the findings on examination and imaging, the neck may need to be treated even when lymph nodes are not obviously enlarged.
Used when lymph-node involvement is known or strongly suspected. The involved lymph-node regions are surgically removed.
In selected clinically node-negative patients, the risk of hidden microscopic nodal disease may justify treatment of the neck.
Sentinel lymph-node biopsy can be considered in selected early oral cavity cancers in centres with appropriate expertise and protocols.
The presence, number, size and characteristics of involved lymph nodes can influence stage and whether additional treatment such as radiation or combined postoperative therapy is recommended.
During cancer surgery, the surgeon aims to remove the tumour with an appropriate margin of surrounding tissue. The removed specimen is then examined by a pathologist.
No cancer is identified at the examined edge of the resected specimen.
Cancer is close to the surgical edge. The significance depends on the tumour site, pathology and the measured distance.
Cancer cells are identified at the examined surgical edge, which can influence the need for further treatment.
Margin status is one of the pathological findings reviewed after surgery. If the final pathology identifies a positive margin or other high-risk features, the multidisciplinary team may discuss additional treatment or further surgery when appropriate.
Larger oral cancer operations can leave defects involving soft tissue, the tongue, jaw or other structures. Reconstruction may be performed during the cancer operation to restore form and support function.
Smaller defects may sometimes be repaired using nearby tissue or regional tissue depending on the location and extent of the defect.
Larger or more complex defects may require tissue transferred from another part of the body using microsurgical techniques.
When part of the jawbone is removed, selected patients may require reconstruction to restore facial structure and support chewing and dental rehabilitation.
Some patients may benefit from dental prostheses or other specialist rehabilitation to improve chewing, swallowing, speech or appearance.
Recovery is not only about wound healing. Depending on the operation, rehabilitation may focus on speech, swallowing, chewing, nutrition and dental function.
Speech and language therapy may help patients adapt to changes following surgery involving the tongue or other structures.
Swallowing assessment and therapy may be required after larger resections or when treatment affects oral and swallowing function.
Nutritional support can help maintain adequate intake before, during and after treatment.
Dental assessment and ongoing oral care are important, particularly when radiation therapy may form part of the treatment plan.
Rehabilitation may help address restricted mouth opening, jaw movement or other functional changes when present.
Psychological and social support can be valuable during treatment and recovery, particularly after major surgery.
Recovery varies considerably depending on the operation, reconstruction, overall health and whether additional treatment is required.
Monitoring of the surgical site, nutrition, pain and other immediate recovery needs.
Final pathology helps establish the tumour characteristics, margins and lymph-node findings.
Radiation or other treatment may be recommended depending on the final pathological risk assessment.
Speech, swallowing, dental, nutritional and other support may continue during recovery.
The final surgical plan should be considered together with pathology, imaging, neck assessment and the possibility of postoperative radiation or other treatment.
For more advanced disease, a multidisciplinary discussion can help coordinate surgery, radiation, medical oncology and rehabilitation.
A surgical consultation can help you understand the proposed operation, neck treatment, reconstruction options, expected functional effects and possible additional treatment.
Book an Oncology ConsultationRadiation therapy uses high-energy radiation to damage cancer cells and prevent them from growing. For oral cavity cancer, radiation may be used after surgery, as a primary treatment in selected situations, or for recurrent disease depending on the clinical circumstances.
Radiation may be recommended after surgery when the final pathology shows features associated with a higher risk of recurrence.
Radiation can be used as a local treatment in selected patients when surgery is not appropriate or when radiation is considered a suitable treatment approach.
Radiation may be considered for selected recurrent tumours, depending on previous treatment, location of recurrence and whether curative local treatment remains possible.
A radiation machine delivers carefully planned radiation from outside the body to the tumour area and, when required, the regional lymph-node areas.
Modern planning techniques aim to shape the radiation dose around the treatment area while reducing exposure to nearby normal tissues where possible.
Before treatment begins, imaging and planning are used to determine the treatment area and dose.
The exact treatment schedule varies according to the treatment intent, tumour location, previous therapy and individual clinical factors.
Chemotherapy is not routinely required for every oral cavity cancer. Its role depends on the extent of disease and whether radiation or other treatment is being given at the same time.
Chemotherapy may be given together with radiation in selected locally advanced disease, particularly when the tumour cannot be adequately treated with surgery alone.
Selected patients with high-risk pathological findings may require additional treatment after surgery. The exact recommendation depends on the final pathology and multidisciplinary assessment.
Systemic chemotherapy may be considered for recurrent or metastatic disease when local treatments alone cannot adequately control the cancer.
Immunotherapy uses the body's immune system to help recognise and attack cancer cells. In oral cavity squamous cell carcinoma, immunotherapy can be used in selected recurrent or metastatic disease.
Pembrolizumab is a PD-1 inhibitor used in selected recurrent or metastatic head and neck squamous cell carcinomas. Treatment selection can depend on factors including PD-L1 expression and the treatment setting.
Nivolumab is another PD-1 inhibitor that may be used in appropriate recurrent or metastatic head and neck squamous cell carcinoma.
The choice between immunotherapy alone, immunotherapy with chemotherapy or another systemic approach depends on the disease setting, previous treatment, biomarker findings and overall health.
In recurrent or metastatic head and neck squamous cell carcinoma, biomarker testing can help inform the suitability of some systemic treatments.
PD-L1 testing may help guide the use of pembrolizumab in selected treatment settings.
Confirmation of the tumour's histology and review of previous pathology are important before systemic treatment decisions are made.
Previous surgery, radiation and systemic therapy can influence which treatments remain appropriate.
When oral cancer returns or spreads, the oncology team reassesses the location and extent of disease and reviews previous treatment before selecting the next approach.
Side effects vary according to the treatment, dose, treatment area and individual health. Your oncology team should explain expected effects and how they can be managed.
Possible effects can include mouth soreness, dry mouth, swallowing difficulty, taste changes, skin reactions and fatigue. Some effects can persist after treatment and require long-term oral care.
Depending on the medicines used, side effects can include fatigue, nausea, reduced blood counts, infection risk, appetite changes and mouth-related symptoms.
Immunotherapy can cause immune-related side effects involving organs such as the skin, bowel, liver, lungs or endocrine glands. Prompt reporting of new symptoms is important.
Supportive care is an important part of oral cancer treatment. Maintaining nutrition and oral health can help patients manage treatment and recovery.
Dental evaluation and preventive care may be particularly important before radiation therapy and during long-term follow-up.
Your team can recommend appropriate oral hygiene and measures to manage soreness, dryness or other treatment-related oral problems.
Nutritional assessment can help maintain adequate calorie, protein and fluid intake, particularly when chewing or swallowing becomes difficult.
Speech and swallowing specialists can support rehabilitation when treatment affects communication or swallowing function.
Pain and other symptoms can often be managed with a combination of medication, local care and supportive interventions.
Psychological, social and practical support can be valuable throughout diagnosis, treatment and recovery.
Clinical trials may investigate new medicines, treatment combinations, radiation approaches, surgical techniques or supportive-care strategies. Eligibility depends on the specific trial and the patient's clinical characteristics.
A clinical trial should be discussed with the treating oncology team as one possible option when appropriate.
The most appropriate treatment sequence depends on the complete diagnosis rather than on the cancer name alone.
The oncology team balances cancer control with preservation or restoration of speech, swallowing, chewing, nutrition, appearance and quality of life.
Your treatment plan should include an explanation of the expected benefits, possible risks, alternatives and potential side effects of the recommended approach.
Bring your biopsy, pathology, scan reports and previous treatment records for a specialist discussion about the next steps.
Book an Oncology ConsultationAn oral cancer diagnosis usually involves several stages of evaluation and decision-making. Your treatment pathway is individualised according to the tumour site, pathology, stage, lymph-node findings, overall health and treatment goals.
Clinical examination and biopsy establish whether the lesion is cancer and identify its type.
Imaging and neck assessment help determine the local, regional and distant extent of disease.
The multidisciplinary team reviews the diagnosis and discusses appropriate treatment options.
Treatment may include surgery, radiation, systemic treatment or a combination, depending on the disease.
Recovery may include dental, nutritional, speech, swallowing and other rehabilitation alongside ongoing follow-up.
Oral cancer treatment can involve multiple oncology disciplines. Surgical, medical and radiation oncology perspectives may be coordinated with dental, nutritional, speech and rehabilitation support according to the patient's needs.
Surgical evaluation of the primary oral tumour, neck lymph nodes, resection requirements, reconstruction and surgical treatment planning.
View Doctor Profile →Evaluation of systemic treatment options, including selected chemotherapy and immunotherapy approaches for appropriate disease settings.
View Doctor Profile →Assessment of the role of radiation therapy before, after or instead of surgery in selected oral cancer situations.
View Doctor Profile →Treatment is not selected from the cancer name alone. Your oncology team considers the complete clinical and pathological picture.
The exact oral cavity site can affect the surgical approach, reconstruction and functional considerations.
Size, depth of invasion and involvement of nearby structures influence staging and treatment.
The presence and characteristics of neck lymph-node disease can change the treatment plan.
Biopsy and surgical pathology provide information about the tumour and surgical margins.
Previous surgery, radiation or systemic therapy is especially important when treating recurrent disease.
Nutrition, dental health, medical conditions, functional priorities and quality-of-life goals are considered alongside cancer control.
A second oncology opinion can provide another specialist review of your diagnosis, pathology, scans and proposed treatment plan. It does not necessarily mean that the first treatment plan is incorrect.
Pathology reports and, when available, pathology slides, imaging reports and scans, clinical findings and the proposed treatment plan.
A second opinion can help you understand the diagnosis, available treatment options, potential benefits and risks, and whether additional information is needed.
Having your previous records together can help the oncology team understand your diagnosis and avoid unnecessary repetition of investigations.
Biopsy report, histopathology report and, where available, pathology slides or blocks when requested for review.
CT, MRI, PET-CT, ultrasound reports and the corresponding imaging discs or digital files when available.
Details of previous surgery, radiation, chemotherapy, immunotherapy or other cancer treatment.
Relevant medical conditions, previous operations and significant dental history.
Current prescription medicines, over-the-counter medicines and supplements.
Write down the questions and concerns that are most important to you before the appointment.
Understanding the diagnosis and treatment plan can make consultations easier to navigate. Consider asking:
Treatment does not end when the tumour has been removed or radiation has finished. Depending on the treatment received, rehabilitation may continue during recovery.
Speech-language support may help patients adapt to changes after surgery or other treatment.
Swallowing assessment and therapy can help address treatment- related changes and support safe eating.
Dietary support can help maintain adequate nutrition during treatment and recovery.
Ongoing dental and oral care is important, particularly after treatment involving radiation.
Rehabilitation may address restricted mouth opening or other changes in jaw and oral function.
Psychological and social support can help patients and families adapt throughout treatment and recovery.
Follow-up is an important part of oral cancer care. Your team will determine the appropriate schedule based on your diagnosis, treatment and individual circumstances.
Tell your healthcare team about a new or persistent mouth ulcer, lump, bleeding, unexplained pain, neck swelling, difficulty swallowing, speech changes, increasing difficulty opening the mouth or other changes that concern you.
Bring your biopsy, pathology, imaging and previous treatment records for a detailed discussion of diagnosis, staging, treatment options and the next steps in your care.
Book an Oncology ConsultationHere are answers to common questions about oral cavity cancer, including symptoms, diagnosis, staging, treatment, surgery, radiation, systemic treatment and follow-up.
Oral cancer is cancer that develops in tissues of the oral cavity, including areas such as the tongue, gums, inner cheek, floor of the mouth, hard palate and retromolar region. Most oral cavity cancers are squamous cell carcinomas.
Oral cavity cancer and oropharyngeal cancer arise in different anatomical regions. Oral cavity cancer involves structures such as the front part of the tongue, gums, inner cheek, floor of the mouth and hard palate, while the oropharynx includes areas such as the tonsils, base of the tongue and soft palate. Their evaluation and treatment can therefore differ.
Possible symptoms include a persistent mouth ulcer, a white or red patch, a lump or thickened area, unexplained bleeding, persistent pain or numbness, difficulty chewing or swallowing, changes in tongue movement, loose teeth, jaw swelling or a persistent lump in the neck. These symptoms can also occur with conditions that are not cancer.
No. Many mouth ulcers have non-cancerous causes. However, an ulcer or other mouth lesion that does not heal, keeps returning, becomes larger or is associated with a lump, bleeding, pain or other concerning changes should be assessed by a healthcare professional.
A persistent or unusual mouth ulcer should be medically assessed rather than repeatedly self-treated. A healthcare professional can determine whether observation, dental treatment, further investigation or biopsy is appropriate.
Important risk factors include tobacco use, areca nut or betel-quid use, alcohol consumption, particularly when combined with tobacco, and previous head and neck cancer. Risk varies between individuals, and oral cancer can also occur in people without these recognised risk factors.
Yes. Tobacco and areca nut exposure are established risk factors for cancers of the oral cavity. Avoiding tobacco, areca nut and betel-quid products can reduce exposure to these known risk factors.
HPV is strongly associated with some cancers of the oropharynx, particularly cancers involving the tonsils and base of the tongue. Its role in cancers of the oral cavity is less clearly established, so HPV-related oropharyngeal cancer should not automatically be equated with oral cavity cancer.
Diagnosis usually begins with an examination of the mouth and neck. If a suspicious lesion is identified, a biopsy may be performed to confirm the diagnosis. Imaging and other investigations may then be used to determine the extent of disease and help with staging.
A biopsy is generally used to establish the histological diagnosis of a suspicious oral lesion. The tissue is examined by a pathologist to determine whether cancer is present and to characterise the tumour.
Depending on the clinical situation, investigations can include CT, MRI, ultrasound of the neck and, in selected circumstances, PET-CT. The choice depends on the suspected tumour location, extent of disease and information already available.
TNM describes the extent of cancer. T refers to the primary tumour, N describes regional lymph-node involvement and M describes distant spread. For oral cavity cancer, factors such as depth of invasion are also incorporated into tumour staging.
Surgery is an important treatment for many oral cavity cancers, particularly when the tumour can be removed safely. Depending on the stage and other features, radiation, systemic treatment or a combination of treatments may also be required.
Not every patient has the same lymph-node management. The decision depends on the tumour characteristics, clinical and imaging findings and the estimated risk of regional disease. Options can include observation, sentinel lymph-node assessment, neck dissection or other treatment when indicated.
Neck dissection is a surgical procedure used to remove lymph nodes and surrounding tissues from selected regions of the neck. It may be performed when lymph-node disease is known or when treatment of the neck is recommended based on the risk of hidden regional disease.
Yes. Some oral cavity tumours can involve nearby bone, including the mandible or maxilla. When this occurs, the surgical approach may need to include removal of the involved bone and, in selected cases, reconstruction.
Radiation may be used after surgery when pathological features indicate a higher risk of recurrence, as a primary treatment in selected situations, or to treat recurrent disease. The indication depends on the tumour, stage, pathology and previous treatment.
Chemotherapy may be combined with radiation in selected locally advanced cancers or used as systemic treatment for recurrent or metastatic disease. The specific treatment depends on the clinical setting and the patient's overall health.
Immunotherapy can be an option for selected patients with recurrent or metastatic head and neck squamous cell carcinoma. Medicines such as pembrolizumab or nivolumab may be considered depending on the disease setting, previous treatment and relevant biomarkers.
Oral cancer can recur after treatment. Recurrence may occur locally, in nearby lymph nodes or, less commonly, at distant sites. Regular follow-up helps the healthcare team assess for recurrence and manage treatment-related effects.
Bring your biopsy and pathology reports, available pathology slides or blocks when requested, imaging reports and scans, previous treatment records, medication details and relevant dental or medical records. A written list of questions can also make the consultation more useful.
Follow-up generally includes clinical examination of the mouth and neck and may include imaging or other investigations when clinically indicated. Dental care, speech and swallowing, nutrition and other treatment-related needs may also be monitored. The follow-up schedule is individualised.
Bring your reports and scans for a detailed discussion about diagnosis, staging, treatment options and the next steps in your care.
Book an Oncology Consultation
Precision Oncology Clinic, the best Cancer Clinic in Bangalore, located in Vijayanagar. Book appointment!
©2024. All Rights Reserved. Precision Oncology Clinic
By HAAPS
Book Appointment